Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19 - Quiz - MDSpire

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19

  • By

  • Hao Cheng

  • Jun Li

  • Ningying Mao

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19

  • by Hao Cheng, Jun Li, Ningying Mao

  • May 1, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Potential targets for boron transport in boron neutron capture therapy

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer